STATEMENTS OF CONDENSED CONSOLIDATED CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (1,514,583)	$ (37,941)
Adjustments to reconcile net loss to net cash provided by operating activities:
Deferred income tax benefit	(473,557)	(11,970)
Depreciation and depletion	422,098	377,116
Impairments of long-lived assets and gain on sale/exchange of long-lived assets	213,727	15,550
Loss (income) from investments	20,785	(11,848)
Loss on debt extinguishment	6,923	4,424
Share-based compensation expense	7,470	6,239
Amortization, accretion and other	13,179	6,342
Loss on derivatives not designated as hedges	3,077,637	188,813
Net cash settlements paid on derivatives not designated as hedges	(885,539)	(38,140)
Net premiums received (paid) on derivative instruments	372	(3,147)
Changes in other assets and liabilities:
Accounts receivable	225,968	(112,899)
Accounts payable	52,867	116,732
Other current assets	(107,455)	(34,066)
Other items, net	(38,673)	(65,290)
Net cash provided by operating activities	1,021,219	399,915
Cash flows from investing activities:
Capital expenditures	(292,281)	(251,277)
Proceeds from sale of assets	1,258	0
Other investing activities	(149)	3,367
Net cash used in investing activities	(291,172)	(247,910)
Cash flows from financing activities:
Proceeds from credit facility borrowings	2,721,000	1,581,000
Repayment of credit facility borrowings	(2,695,000)	(1,581,000)
Repayment and retirement of debt	(570,174)	(126,396)
Premiums paid on debt extinguishment	(6,240)	(4,267)
Dividends paid	(47,063)	0
Cash paid for taxes related to net settlement of share-based incentive awards	(13,648)	(2,632)
Proceeds from exercises under employee compensation plans	1,214	0
Repurchase and retirement of common stock	(216,491)	0
(Distribution to) contribution from noncontrolling interest	(341)	3,750
Other financing activities	(354)	0
Net cash used in financing activities	(827,097)	(129,545)
Net change in cash and cash equivalents	(97,050)	22,460
Cash and cash equivalents at beginning of period	113,963	18,210
Cash and cash equivalents at end of period	$ 16,913	$ 40,670